Leverkusen, Germany

Daniel Meibom

USPTO Granted Patents = 25 

 

 

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 94(Granted Patents)


Location History:

  • Leverkusen, DE (2011 - 2016)
  • Wuppertal, DE (2015 - 2021)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):

Title: The Innovative Contributions of Daniel Meibom

Introduction

Daniel Meibom, an accomplished inventor based in Leverkusen, Germany, has made significant contributions to the field of medicinal chemistry. With an impressive portfolio of 24 patents, he has dedicated his career to developing innovative solutions for various medical conditions, particularly in the realms of cardiovascular and inflammatory disorders.

Latest Patents

Among Daniel's latest innovations are two notable patents. The first patent focuses on "Substituted oxopyridine derivatives," which are primarily concerned with the preparation and application of these compounds in creating medicaments aimed at treating cardiovascular disorders, thrombotic or thromboembolic diseases, and ophthalmic issues. The second patent involves "Substituted N,2-diarylquinoline-4-carboxamides," which highlights novel derivatives used as anti-inflammatory agents. This invention addresses the treatment and prevention of fibrotic and inflammatory disorders, showcasing his commitment to improving healthcare through scientific innovation.

Career Highlights

Daniel has held key positions in several prestigious organizations, notably Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His work in these companies has not only contributed to his personal growth as an inventor but has also been instrumental in driving forward the research and development of new pharmaceuticals.

Collaborations

Throughout his career, Daniel has had the privilege of collaborating with talented professionals such as Alexandros Vakalopoulos and Barbara Albrecht-Küpper. These partnerships have undoubtedly enriched his work and facilitated the exchange of innovative ideas and practices within the field.

Conclusion

Daniel Meibom stands out as a prominent figure in the world of pharmaceuticals and medicinal research. His extensive patent portfolio and collaborative efforts underline his role as a leading inventor, dedicated to advancing medical science and enhancing the quality of life through targeted innovations. As the landscape of medicinal chemistry continues to evolve, Daniel’s contributions are likely to have a lasting impact on the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…